Howland E. Crosswell

642 total citations
22 papers, 339 citations indexed

About

Howland E. Crosswell is a scholar working on Oncology, Genetics and Pathology and Forensic Medicine. According to data from OpenAlex, Howland E. Crosswell has authored 22 papers receiving a total of 339 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 7 papers in Genetics and 6 papers in Pathology and Forensic Medicine. Recurrent topics in Howland E. Crosswell's work include Childhood Cancer Survivors' Quality of Life (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Howland E. Crosswell is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (6 papers), Lymphoma Diagnosis and Treatment (6 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Howland E. Crosswell collaborates with scholars based in United States, Canada and Australia. Howland E. Crosswell's co-authors include Ann S. LaCasce, Neil C. Josephson, Ahmed Sawas, Caroline Behler, Stephen M. Ansell, Miguel Islas‐Ohlmayer, Julie M. Vose, Jeffrey Matous, Eric Cheung and Ranjana H. Advani and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Howland E. Crosswell

18 papers receiving 338 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Howland E. Crosswell United States	7	214	182	116	59	37	22	339
Mohammed Al‐Hamadani United States	5	178 0.8×	170 0.9×	49 0.4×	77 1.3×	24 0.6×	10	302
Heiner Zimmermann Germany	10	266 1.2×	425 2.3×	50 0.4×	42 0.7×	12 0.3×	20	508
Kevin Imrie Canada	11	153 0.7×	140 0.8×	60 0.5×	62 1.1×	36 1.0×	16	332
Gottfried Doelken Germany	8	179 0.8×	174 1.0×	77 0.7×	68 1.2×	56 1.5×	15	296
F Cavalli Switzerland	11	206 1.0×	154 0.8×	50 0.4×	81 1.4×	63 1.7×	42	366
Zeina Al‐Mansour United States	7	96 0.4×	218 1.2×	29 0.3×	24 0.4×	12 0.3×	20	319
Lara Malerba Italy	11	84 0.4×	151 0.8×	38 0.3×	52 0.9×	19 0.5×	18	261
Mona Shafey Canada	9	69 0.3×	96 0.5×	29 0.3×	45 0.8×	25 0.7×	36	245
Dominic Kaddu‐Mulindwa Germany	8	76 0.4×	100 0.5×	37 0.3×	58 1.0×	38 1.0×	37	296
Anne Marie Young United Kingdom	6	179 0.8×	308 1.7×	71 0.6×	46 0.8×	9 0.2×	6	405

Countries citing papers authored by Howland E. Crosswell

Since Specialization

Citations

This map shows the geographic impact of Howland E. Crosswell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Howland E. Crosswell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Howland E. Crosswell more than expected).

Fields of papers citing papers by Howland E. Crosswell

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Howland E. Crosswell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Howland E. Crosswell. The network helps show where Howland E. Crosswell may publish in the future.

Co-authorship network of co-authors of Howland E. Crosswell

This figure shows the co-authorship network connecting the top 25 collaborators of Howland E. Crosswell. A scholar is included among the top collaborators of Howland E. Crosswell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Howland E. Crosswell. Howland E. Crosswell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zheng, Daniel J., Angie Mae Rodday, Melissa Beauchemin, et al.. (2025). “Nothing Is as Great a Learning Experience as Getting a $15,000 Bill”: A Mixed-Methods Study of Young Adult Cancer Survivors' Experience With Insurance Coverage. JCO Oncology Practice. 22(3). 445–454.

Parsons, Susan K., Angie Mae Rodday, Michael Roth, et al.. (2024). Financial distress and medical financial hardship among young adult survivors of blood cancer. JNCI Cancer Spectrum. 8(5). 2 indexed citations

Parsons, Susan K., Angie Mae Rodday, Kimberly A. Miller, et al.. (2023). Status of survivorship care among young adult survivors of leukemia or lymphoma.. JCO Oncology Practice. 19(11_suppl). 491–491.

Siembida, Elizabeth J., Holli A. Loomans‐Kropp, Irene Tamí‐Maury, et al.. (2022). Comparing Barriers and Facilitators to Adolescent and Young Adult Clinical Trial Enrollment Across High- and Low-Enrolling Community-Based Clinics. The Oncologist. 27(5). 363–370. 4 indexed citations

Siembida, Elizabeth J., Holli A. Loomans‐Kropp, Irene Tamí‐Maury, et al.. (2021). Barriers and Facilitators to Adolescent and Young Adult Cancer Trial Enrollment: NCORP Site Perspectives. JNCI Cancer Spectrum. 5(3). 21 indexed citations

Crosswell, Howland E., Ann S. LaCasce, Nancy L. Bartlett, et al.. (2021). Brentuximab vedotin with chemotherapy in adolescents and young adults (AYAs) with stage III or IV Hodgkin lymphoma: A subgroup analysis from the phase 3 Echelon-1 study.. Journal of Clinical Oncology. 39(15_suppl). 7528–7528. 4 indexed citations

Walker, Alison R., John C. Byrd, James S. Blachly, et al.. (2020). Entospletinib in Combination with Induction Chemotherapy in Previously Untreated Acute Myeloid Leukemia: Response and Predictive Significance of HOXA9 and MEIS1 Expression. Clinical Cancer Research. 26(22). 5852–5859. 27 indexed citations

Fried, Daniel B., et al.. (2019). Complete Response to Dual Immunotherapy in a Young Adult with Metastatic Alveolar Soft Part Sarcoma Enabled by a Drug Recovery Program in a Community Practice. Journal of Adolescent and Young Adult Oncology. 9(3). 449–452. 5 indexed citations

Siegel, Robert D., et al.. (2019). Drug Recovery and Copay Assistance Program in a Community Cancer Center: Charity and Challenges. Journal of Oncology Practice. 15(7). e628–e635. 8 indexed citations

10.

LaCasce, Ann S., R. Gregory Bociek, Ahmed Sawas, et al.. (2018). Brentuximab vedotin plus bendamustine: a highly active first salvage regimen for relapsed or refractory Hodgkin lymphoma. Blood. 132(1). 40–48. 152 indexed citations

11.

Crosswell, Howland E., Ann S. LaCasce, Nancy L. Bartlett, et al.. (2018). Brentuximab Vedotin with Chemotherapy in Adolescents and Young Adults (AYA) with Stage III or IV Hodgkin Lymphoma: A Subgroup Analysis from the Phase 3 Echelon-1 Study. Blood. 132(Supplement 1). 1647–1647. 2 indexed citations

12.

Smith, Ashley M., Melissa Millard, Lillia Holmes, et al.. (2018). Abstract 1121: Profiling patient-specific glioblastoma drug response in vitro using complex 3D microtumors. Cancer Research. 78(13_Supplement). 1121–1121. 1 indexed citations

13.

Walker, Alison R., John C. Byrd, William Blum, et al.. (2018). Abstract 819: High response rates with entospletinib in patients with t(v;11q23.3);KMT2A rearranged acute myeloid leukemia and acute lymphoblastic leukemia. Cancer Research. 78(13_Supplement). 819–819. 1 indexed citations

14.

Crosswell, Howland E., et al.. (2017). Trials and Tribulations for Adolescents and Young Adults with Cancer: Measuring the Impact of a Community-Based Program. Journal of the National Comprehensive Cancer Network. 15(9). 1171–1176. 2 indexed citations

15.

Srivastava, Shashikant, Jotam G. Pasipanodya, Geetha Ramachandran, et al.. (2016). A Long-term Co-perfused Disseminated Tuberculosis-3D Liver Hollow Fiber Model for Both Drug Efficacy and Hepatotoxicity in Babies. EBioMedicine. 6. 126–138. 38 indexed citations

16.

LaCasce, Ann S., Gregory Bociek, Ahmed Sawas, et al.. (2015). Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma. Blood. 126(23). 3982–3982. 43 indexed citations

17.

DesRochers, Teresa M., Lillia Holmes, Lauren J. O’Donnell, et al.. (2015). Macrophage incorporation into a 3D perfusion tri-culture model of human breast cancer. Journal for ImmunoTherapy of Cancer. 3(S2). 5 indexed citations

18.

LaCasce, Ann S., R. Gregory Bociek, Jeffrey Matous, et al.. (2014). Brentuximab Vedotin in Combination with Bendamustine for Patients with Hodgkin Lymphoma who are Relapsed or Refractory after Frontline Therapy. Blood. 124(21). 293–293. 20 indexed citations

19.

Crosswell, Howland E., et al.. (2007). Successful treatment with modified CHOP‐rituximab in pediatric AIDS‐related advanced stage Burkitt lymphoma. Pediatric Blood & Cancer. 50(4). 883–885. 2 indexed citations

20.

Crosswell, Howland E., Qiong Peng, Chengyu Prince, Pradip De, & Donald L. Durden. (2006). Targeting PI3K in alveolar rhabdomyosarcoma (aRMS). Journal of Clinical Oncology. 24(18_suppl). 10025–10025.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact